QRVO
4
2
DFS
60
4
WBA
53
5
IPG
50
2
VLO
33
3
STZ
47
-3
EQT
30
5
MKC
56
3
MTCH
53
3
UNP
48
6
YUM
43
5
CME
56
3
WU
36
2
AIZ
54
7
PGR
58
6
SJM
19
5
PNR
69
6
HSIC
36
-9
PWR
66
7
AVB
54
9
QRVO
4
2
DFS
60
4
WBA
53
5
IPG
50
2
VLO
33
3
STZ
47
-3
EQT
30
5
MKC
56
3
MTCH
53
3
UNP
48
6
YUM
43
5
CME
56
3
WU
36
2
AIZ
54
7
PGR
58
6
SJM
19
5
PNR
69
6
HSIC
36
-9
PWR
66
7
AVB
54
9
Financhill
Back

Seelos Therapeutics 10K Form

Sell
7

SEEL
Seelos Therapeutics

Last Price:
0.68
Seasonality Move:
23.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SEEL News And Ratings

See the #1 stock for the next 7 days that we like better than SEEL

SEEL Financial Statistics

Sales & Book Value

Annual Sales: $4.84M
Cash Flow: $-972K
Price / Cash Flow: 0
Annual Sales: $-135.52
Price / Book: 0

Profitability

EPS (TTM): -475.52000
Net Income (TTM): $4.09M
Gross Margin: $3.92M
Return on Equity: 0%
Return on Assets: 0%

Seelos Therapeutics Earnings Forecast

Key Seelos Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 17 years for SEEL is 80.95%.
  • The Selling, General & Administrative Expenses for SEEL have been equal to 217.32% of Gross Profit Margin.
  • The Interest Expense is -0.20% of Operating Income.
  • Per Share Earnings over the last 27 years have been positive in 16 years.

Seelos Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SEEL
CUSIP: 81577F
Website: seelostherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SEEL Technical Analysis vs Fundamental Analysis

Sell
7
Seelos Therapeutics (SEEL) is a Sell

Is Seelos Therapeutics a Buy or a Sell?